Lutropin alpha, recombinant human luteinizing hormone, for the stimulation of follicular development in profoundly LH-deficient hypogonadotropic hypogonadal women: A review

Biologics: Targets and Therapy

Volumn 3, Issue , 2009, Pages 337-347

  Krause, Bernd Th ^a   Ohlinger, Ralf ^b   Haase, Annette ^c  

^a Center for Endocrinology and Reproductive Medicine MVZ Uhlandstr   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c NONE   (Germany)

Author keywords

Hypogonadotropic hypogonadism; Ovarian stimulation; Ovulation induction; Recombinant luteinizing hormone

Indexed keywords

EID: 84857715375     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: 10.2147/BTT.S3307     Document Type: Review

References (108)

1. Kaufmann R, Dunn R, Vaughn T, et al. Recombinant human luteinizing hormone, lutropin alfa, for the induction of follicular development and pregnancy in profoundly gonadotrophin-deficient women. Clin Endocrinol. 2007;67(4):563-569.
2. Reame NE, Sauder ED, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin releasing hormone secretion is the mechanism of persistant anovulation. J Clin Endocrinol Metab. 1985;61(5):851-858.
3. Layman LC. The molecular basis of human hypogonadotropic hypogonadism. Mol Gen Metab. 1999;68(2):191-199.
4. Meysing AU, Kanasaki H, Bedecarrats GY, et al. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone. J Clin Endocrinol Metab. 2004;89(7):3189-3198.
5. Warren MP. Evaluation of secondary amenorrhea. J Clin Endocrinol Metab. 1996;81(2):437-442.
6. Halasz B, Kiss J, Molnar J. Regulation of the gonadotropin-releasing hormone (GnRH) neuronal system: morphological aspects. J Steroid Biochem. 1989;33(4):663-668.
7. Kessel B, Dahl KD, Kazer RR, et al. The dependency of bioactive follicle-stimulating hormone secretion on gonadotropin-releasing hormone in hypogonadal and cycling women. J Clin Endocrinol Metab. 1988;66(2):361-366.
8. Santen RJ, Manni A, Harvey H. Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma. Breast Cancer Res Treat. 1986;7(3):129-145.
9. Hales TG, Sanderson MJ, Charles AC. GABA has excitatory actions on GnRH-secreting immortalized hypothalamic (GT1-7) neurons. Neuroendocrinology. 1994;59(3):297-308.
10. Bommer M, Nikolarakis K, Noble EP, Herz A. In vivo modulation of rat hypothalamic opioid peptide content by intracerebroventricular injection of guanidinoethylmercaptosuccinic acid (GEMSA): possible physiological role of enkephalin convertase. Brain Res. 1989; 492(1-2):305-313.
11. Thind KK, Boggan JE, Goldsmith PC. Neuropeptide Y system of the female monkey hypothalamus: retrograde tracing and immunostaining. Neuroendocrinology. 1993;57(2):289-298.
12. Grafstein-Dunn E, Clifton DK, Steiner RA. Regulation of galanin and gonadotropin-releasing hormone gene expression in the hypothalamus and basal forebrain of the rat. Horm Behav. 1994;28(4): 417-423.
13. Nishihara M, Hiruma H, Kimura F. Interactions between the noradrenergic and opioid peptidergic systems in controlling the electrical activity of luteinizing hormone-releasing hormone pulse generator in ovariectomized rats. Neuroendocrinology. 1991;54(4):321-326.
14. Marshall JC, Eagleson CA, McCartney CR. Hypothalamic dysfunction. Mol Cell Endocrinol. 2002;186(2):227-230.
15. Martin KA, Hall JE, Adams JM, Cowley, Jr WF. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab. 1993;77(1):125-129.
16. Liu JH. Hypothalamic amenorrhea: clinical perspectives, pathophysiology, and management. Am J Obstet Gynecol. 1990;163(5): 1732-1736.
17. Gompel A, Mauvais-Jarvis P. Induction of ovulation with pulsatile GnRH in hypothalamic amenorrhoea. Hum Reprod. 1988;3(4): 473-477.
18. McGee EA, Hsueh AJW. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21(2):200-214.
19. Oktay K, Briggs D, Gosden RG. Ontogeny of follicle-stimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab. 1997;82(11):3748-3751.
20. Goldenberg RL, Powell RD, Rosen SW, et al. Ovarian morphology in women with anosmia and hypogonadotropic hypogonadism. Am J Obstet Gynecol. 1976;126(1):91-94.
21. Barnes RB, Namnoum AB, Rosenfield RL, Layman LC. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002;17(1):88-91.
22. McCartney CR, Gingrich MB, Hu Y, Evans WS, Marshall JC. Hypothalamic regulation of cyclic ovulation: evidence that the increase in gonadotropin-releasing hormone pulse frequency during the follicular phase reflects the gradual loss of the restraining effects of progesterone. J of Clin Endocrinol Metab. 2002;87(5): 2194-2200.
23. Fowler PA, Templeton A, Messinis IE. The ovarian modulation of gonadotrophin releasing hormone-induced luteinizing hormone secretion in women. Hum Reprod. 1993;8 Suppl 2:S112-S116.
24. Hall JE, Schoenfeld DA, Martin KA, et al. Hypothalamic gonadotropinreleasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab. 1992; 74(3):600-607.
25. Stouffer RL, Woodruff TK, Dahl KD, Hess DL, Mather JP, Molskness TA. Human recombinant activin-a alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in Rhesus monkeys. J Clin Endocrinol Metab. 1993;77(1):241-248.
26. Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170-207.
27. Ryan KJ, Petro Z, Kaiser J. Steroid formation by isolated and recombined ovarian granulosa and tehcal cells. J Clin Endocrinol Metab. 1968;28(3):355-358.
28. Hillier SG. Gonadotropic control of ovarian follicular growth and development. Mol Cell Endocrinol. 2001;179(1-2):39-46.
29. Filicori M, Santoro N, Merriam GR, Crowley WF Jr. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab. 1986;62(6):1136-1144.
30. Hsieh M, Lee D, Panigone S, Horner K, et al. Luteinizing hormonedependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol. 2007;27(5):1914-1924.
31. Bergendah M, Veldhuis JD. Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?III. Luteinizing hormone heterogeneity: a medical physiologist's perspective. Hum Reprod. 2001;16(6):1058-1064.
32. Louvet JP, Harman SM, Schrieber JR, Ross GT. Evidence of a role of adrogens in follicular maturation. Endocrinology. 1975;97(2): 366-372.
33. Filicori M, Cognigni GE. Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction. J Clin Endocrinol Metab. 2001;86(4):1437-1441.
34. Lossl K, Andersen AN, Loft A, et al. Androgen priming using aromatase inhibitor and hCG during early-follicular-phase GnRH antagonist down-regulation in modified antagonist protocols. Hum Reprodu. 2006;21(10):2593-2600.
35. Padmanabhan V, Lang LL, Sonstein J, Kelch RP, Beitins IZ. Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J Clin Endocrinol Metab. 1988;67(3):465-473.
36. Fauser BCJM, van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. 1997; Endocr Rev. 1997;18(1):71-106.
37. Van Santbrink EJP, van Dessel HJHM, Hop WC, De Jong FH, Fauser BCJM. Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril. 1995;64(1):37-43.
38. Hillier SG. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod. 1994;9(2): 188-191.
39. Filicori M, Cognigni GE, Taraborrelli S, et al. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab. 1999;84(8):2659-2663.
40. Richards JS. Maturation of ovarian follicles: actions and interactions of pituitary and ovarian hormones on follicular cell differentiation. Physiol Rev. 1980;60(1):51-89.
41. Yamoto M, Shima K, Nakano R. Gonadotropin receptors in human ovarian follicles and corpora lutea throughout the menstrual cycle. Horm Res. 1992;37(1):5-11.
42. Zeleznik AJ, Midgley AR Jr, Reichert LE Jr. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology. 1974;95(3):818-825.
43. Shima K, Kitayama S, Nakano R. Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet Gynecol. 1987;69(5):800-806.
44. Rani CS, Salhanick AR, Armstrong DT. Follicle-stimulating hormone induction of luteinizing hormone receptor in cultured rat granulosa cells: an examination of the need for steroids in the induction process. Endocrinology. 1981;108(4):1379-1385.
45. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 1996;81(4): 1401-1405.
46. Zeleznik AJ, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynaecol. 1984;27(4): 927-940.
47. Sullivan MW, Stewart-Akers A, Krasnow JS, Berga SL, Zeleznik AJ. Ovarian responses in women to recombinant folliclestimulating hormone and luteinizing hormone (LH): A role for LH in the final stages of follicular maturation. J Clin Endocrinol Metab. 1999;84(1):228-232.
48. Loumaye E, Engrand P, Shoham Z, Hillier SG, Baird DT. Clinical evidence for an LH 'ceiling' effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation. Hum Reprod. 2003;18(2)314-322.
49. Zeleznik AJ, Kubik CJ. Ovarian responses in macaques to pulsatile infusion of follicle-stimulating hormone (FSH) and luteinizing hormone: increased sensitivity of the maturing follicle to FSH. Endocrinology. 1986;119(5):2025-2032.
50. Yong EL, Baird DT, Yates R, Reichert LE Jr, Hillier SG. Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab. 1992;74(4):842-849.
51. Hugues JN, Soussis J, Calderon I. Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-fi{ligature}nding study. Hum Reprod. 2005;20(3):629-635.
52. Filicori M, Cognigni GE, Taraborrelli S, et al. Stimulation and growth of antral ovarian follicles by selective lh activity administration in women. J Clin Endocrinol Metab. 2002;87(3):1156-1161.
53. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab. 1988;66(3):552-556.
54. Campbell BK, Dobson H, Baird DT, Scaramuzzi RJ. Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep. J Reprod Fertil. 1999;117(2):355-367.
55. Sasson R, Rimon E, Dantes A, et al. Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signalling and protein kinases. Mol Hum Reprod. 2004; 10(5):299-311.
56. Lobb DK, Soliman SR, Daya S, Younglai EV. Steroidogenesis in luteinized granulosa cell cultures varies with follicular priming regimen. Hum Reprod. 1998;13(8):2064-2067.
57. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G. Effects of human recombinant luteinizing hormone and folliclestimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of sertoli and leydig cell secretions and interactions. J Clin Endocrinol Metab. 2000;85(9):3239-3244.
58. Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465-495.
59. Gharib SD, Wierman ME, Shupnik MA, et al. Molecular biology of the pituitary gonadotropins. Endocr Rev. 1990;11(1):177-199.
60. Ulloa-Aquirre A, Espinoza R, Damian-Matsumura P, Chappel SC. Immunological and biological potencies of different molecular species of gonadotrophins. Hum Reprod. 1988;3(4):491-501.
61. Filicori M, Cognigni GE, Taraborrelli S, et al. Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab. 2001;86(1): 337-343.
62. Talmadge K, Vamvakopoulos NC, Fiddes JC. Evolution of the genes for the beta subunits of human chorionic gonadotropin and luteinizing hormone. Nature. 1984;307(5946):37-40.
63. Baer G, Loumaye E. Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology. Curr Med Res Opin. 2003;19(2): 83-88.
64. Porchet H, Le Cotonnec JY, Neuteboom B, Canali S, Zanolo G. Pharmacokinetics of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J Clin Endocrinol Metab. 1995;80(2): 667-673.
65. Crowley Jr. WF, McArthur JW. Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J Clin Endocrinol Metab. 1980;51(1):173-175.
66. Balen AH, Braat DDM, West C, Patel A, Jacobs HS. Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod. 1994;9(8):1563-1570.
67. Navot D, Relou A, Birkenfeld A, Rabinowitz R, Brzezinski A, Margalioth EJ. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 1988;159(1):210-215.
68. Berger MJ, Taymor ML. The role of luteinizing hormone in human follicular maturation and function. Am J Obstet Gynecol. 1971;111(5): 708-710.
69. Fox R, Ekeroma A, Wardle P. Ovarian response to purified FSH in infertile women with long-standing hypogonadotrophic hypogonadism. Aust N Z J Obstet Gynaecol. 1997;37(1):92-94.
70. Schoot DC, Harlin J, Shoham Z, et al. Recombinant human folliclestimulating hormone and ovarian response in gonadotrophin-defi{ligature}cient women. Hum Reprod. 1994;9(7):1237-1242.
71. Shoham Z, Balen A, Patel A, Jacobs HS. Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril. 1991;56(6):1048-1053.
72. Schoot DC, Coelingh Bennink HJ, Mannaerts BM, Lamberts SW, Bouchard P, Fauser BC. Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J Clin Endocrinol Metab. 1992;74(6): 1471-1473.
73. Shoham Z, Mannaerts B, Insler V, Coelingh-Bennink H. Induction of follicular growth using recombinant human follicle-stimulating hormone in two volunteer women with hypogonadotropic hypogonadism. Fertil Steril. 1993;59(4):738-742.
74. Balasch J, Miró F, Burzaco I, et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod. 1995;10(7):1678-1683.
75. Glasier AF, Wickings EJ, Hillier SG, et al. Both LH and FSH are required for the development of the normal follicle. J Endocrinol. 1988; 119(Suppl):A-159.
76. Huirne JAF, van Loenen ACD, Schats R, et al. Dose-finding study of daily GnRH antagonist forthe prevention of premature LH surges in IVF/ICSIpatients: optimal changes in LH and progesteronefor clinical pregnancy. Hum Reprod. 2005;20(2):359-367.
77. Hsueh AJ, Adashi EY, Jones PB, et al. Hormonal regulation of the differentiation of cultured ovarian granulosa cells. Endocr Rev. 1984;5(1):76-127.
78. Murray AA, Swales AKE, Smith RE, Molinek MD, Hillier SG, Spears N. Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids. Mol Hum Reprod. 2008;14(2):75-83.
79. Balasch J. The potential value of mid-follicular phase LH. Hum Reprod. 2002;17(2):517-523.
80. Rabinovici J, Blankstein J, Goldman B, et al. In vitro fertilization and primary embryonic cleavage are possible in 17 alpha-hydroxylase deficiency despite extremely low intrafollicular 17 beta-estradiol. J Clin Endocrinol Metab. 1989;68(3):693-697.
81. Loumaye E, Engrand P, Howles CM, O'Dea L. Assessment of the role of serum luteinizing hormone and estradiol response to folliclestimulating hormone on in vitro fertilization treatment outcome. Fertil Steril. 1997;67(5):889-899.
82. Regan L, Owen EJ, Jacobs HS. Hypersecretion of luteinising hormone, infertility, and miscarriage. Lancet. 1990;336(8724):1141-1144.
83. Watson H, Kiddy DS, Diana Hamilton-Fairley D, et al. Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage Hum Reprod. 1993;8(6):829-833.
84. Howles CM. Role of LH and FSH in ovarian function. Mol Cell Endocrinol. 2000;161(1-2):25-30.
85. Daya S, Gunby J, Hughes EG, Collins JA, Sagle MA. Folliclestimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil Steril. 1995;64(2):347-54.
86. Hillier SG. Ovarian stimulation with recombinant gonadotrophins: LH as adjunct to FSH. In: Jacobs HS, editor. The new frontier in ovulation induction. Carnforth: Parthenon; 1993. p. 39-47.
87. Gordon UD, Harrison RF, Fawzy M, et al. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril. 2001;75(2):324-331.
88. Agrawal R, Holmes J, Jacobs HS. Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulationin in vitro fertilization cycles: a meta-analysis. Fertil Steril. 2000;73(2):338-343.
89. Check JH, Nazari P, Choe JK, et al. Evaluation of pregnancy and implantation rates following controlled ovarian hyperstimulation (COH) using all follicle stimulating hormone (FSH) versus FSH/luteinizing hormone (LH) combination according to the serum LH obtained in the early follicular phase. Fertil Steril. 2000;74(3 Suppl):S228.
90. Ng EHY, Lau EYL, Yeung WSB, Ho PC. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum Reprod. 2001;16(2):319-325.
91. Van Wely M, Westergaard LG, Bossuyt PMM, Van der Veen F. Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003; Issue 1. Art. No.: CD003973. DOI: 10.1002/14651858.CD003973.
92. Weghofer A, Munne S, Brannath W, et al. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation Hum Reprod. 2008;23(3):499-503.
93. Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod. 1990;5(4):357-376.
94. Sills ES, Levy DP, Moomjy M, McGee M, Rosenwaks Z. A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum Reprod. 1999;14(9): 2230-2235.
95. Balasch J, Vidal E, Peñarrubia J, et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod. 2001;16(8): 1636-1643.
96. Hsieh M, Lee D, Panigone S, et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol. 2007;27(5):1914-1924.
97. Verlinsky Y, Kuliev A. Preimplantation diagnosis of common andiploidies in infertile couples of advanced maternal age. Hum Reprod. 1996;11(10):2076-2077.
98. Yim SF, Lok IH, Cheung LP, Briton-Jones CM, Chiu TTY, Haines CJ. Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF. Hum Reprod. 2001;16(3):492-494.
99. Ben-Chetrit A, Gotlieb L, Wong PY, Casper RF. Ovarian response to recombinant human follicle stimulating hormone in luteinizing hormonedepleted women: examination of the two cell, two gonadotropin theory. Fertil Steril. 1996;65(4):711-717.
100. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15(5):1003-1008.
101. Kolibianakis EM, Collins J, Tarlatzis B, et al. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update. 2006;12(1):3-12.
102. Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril. 2002;77(6): 1170-1177.
103. Burgues S. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum Reprod. 2001;16(12):2525-2532.
104. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH-and FSH-deficient anovulatory women: A dose-finding study. J Clin Endocrinol Metab. 1998;83(5):1507-1514.
105. Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod. 1991;6(9):1206-1212.
106. Shoham Z, Smith H, Yeko T, O'Brien F, Hemsey G, O'Dea L. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, doubleblind, placebo-controlled, proof-of-efficacy study. Clin Endocrinol. 2008;69(3):471-478.
107. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT. Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenousfollicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril. 1999;72(6): 1118-1120.
108. O'Dea L, O'Brien F, Hemsey G, Dunn RC, Kaufmann R, Vaughn T. Flexible dosing of recombinant human follitropin alfa (r-hFSH) optimizes pregnancy rates for profoundly luteinizing hormone (LH)-defi{ligature}cient hypogonadotropic hypogonadal patients treated with recombinant human lutropin alfa (r-hLH). Fertil Steril. 2004;82(2):307.